BIA response to Life Sciences Sector Plan
Responding to the Life Sciences Sector Plan, BIA Chair Dr Daniel Mahony said:
Making the UK an outstanding place in which to start, grow, scale and invest in life science companies is key to driving UK economic growth. The life science sector plan is right to focus on getting substantially more public and private investment in early-stage companies, improved access to data, trials and skills to help companies grow, and more streamlined regulation and market access pathways to get innovative medicines to NHS patients. We particularly welcome the focus on unlocking pension funds to increase investment in scaling life science companies. In this parliament, the UK has the opportunity to create a truly-world leading life sciences ecosystem that works for start-ups, scale-ups and established global companies alike.
